Harnessing CRISPR-Cas9 as an anti-mycobacterial system
- 2 February 2023
- journal article
- research article
- Published by Elsevier in Microbiological Research
- Vol. 270, 127319
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Identification of a Novel Conjugative Plasmid in Mycobacteria That Requires Both Type IV and Type VII SecretionmBio, 2014
- Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobialsNature Biotechnology, 2014
- Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleasesNature Biotechnology, 2014
- Double-Strand DNA Break Repair in MycobacteriaMicrobiology Spectrum, 2014
- Programmable Removal of Bacterial Strains by Use of Genome-Targeting CRISPR-Cas SystemsmBio, 2014
- DNA interrogation by the CRISPR RNA-guided endonuclease Cas9Nature, 2014
- Systemic Analysis of PPARγ in Mouse Macrophage Populations Reveals Marked Diversity in Expression with Critical Roles in Resolution of Inflammation and Airway ImmunityThe Journal of Immunology, 2012
- Mycobacteria exploit three genetically distinct DNA double‐strand break repair pathwaysMolecular Microbiology, 2010
- Identification of outer membrane proteins of Mycobacterium tuberculosisTuberculosis, 2008
- The pathways and outcomes of mycobacterial NHEJ depend on the structure of the broken DNA endsGenes & Development, 2008